Company intelligence / Profile preview

Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant

Tianjin, Tianjin, China
Ownership
Private
Employees
~300
Development stage
Other
01

Overview

Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant (now known as Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited No. 6 Chinese Medicine Plant) is a leading Chinese pharmaceutical manufacturer specializing in modern traditional Chinese medicine (TCM) dripping pills. Founded in 1958 and based in Tianjin, China, the plant is renowned as the first GMP-certified TCM enterprise in China and the country's only 'TCM Dripping Pill Quality Management Demonstration Base.' Its flagship product, Suxiao Jiuxin Pill (速效救心丸), is a national-level confidential formula widely used for the emergency treatment of coronary heart disease and angina pectoris. The company also produces other notable TCM dripping pill products, including Shunaoxin Dripping Pills for migraines and Qingyan Dripping Pills for throat irritation. Utilizing advanced automated manufacturing technologies, the plant integrates traditional herbal medicine with modern pharmaceutical standards.

Therapeutic areas
Infectious DiseasesOtherNeurologyCardiovascularPulmonology
Modalities
Herbal medicineBotanical extractPlant extract
Industry
Pharma
02

Drug pipeline

1 asset

Shu Nao Xin Dripping Pill

Unknown

Beyond the preview

Go deeper on Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin Zhongxin Pharmaceutical Group No. 6 Chinese Medicine Plant.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call